Clinigen Group PLC (LON:CLIN) has been given an average rating of “Buy” by the six research firms that are presently covering the stock, Marketbeat.com reports. Two analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 12-month price objective among brokerages that have issued ratings on the stock in the last year is GBX 1,145.83 ($15.07).

Several equities analysts have recently weighed in on CLIN shares. Peel Hunt upgraded Clinigen Group PLC to a “buy” rating and lifted their price target for the company from GBX 1,200 ($15.78) to GBX 1,350 ($17.76) in a research report on Tuesday, October 10th. Royal Bank Of Canada reiterated an “outperform” rating and issued a GBX 1,360 ($17.89) price target on shares of Clinigen Group PLC in a research report on Tuesday. Berenberg Bank started coverage on Clinigen Group PLC in a research report on Wednesday, November 1st. They issued a “hold” rating and a GBX 1,200 ($15.78) price target for the company. Finally, Numis Securities Ltd cut Clinigen Group PLC to an “add” rating and set a GBX 1,100 ($14.47) price target for the company. in a research report on Tuesday, July 18th.

Shares of Clinigen Group PLC (LON CLIN) opened at GBX 1,112 ($14.63) on Tuesday. Clinigen Group PLC has a 52-week low of GBX 695 ($9.14) and a 52-week high of GBX 1,187 ($15.61).

Clinigen Group PLC (LON:CLIN) last announced its quarterly earnings results on Thursday, September 28th. The company reported GBX 41.80 ($0.55) earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of GBX 41.20 ($0.54) by GBX 0.60 ($0.01). The company had revenue of £302.30 million during the quarter. Clinigen Group PLC had a return on equity of 0.98% and a net margin of 0.70%.

The business also recently announced a dividend, which will be paid on Friday, December 1st. Stockholders of record on Thursday, November 9th will be paid a GBX 3.40 ($0.04) dividend. This represents a dividend yield of 0.32%. The ex-dividend date of this dividend is Thursday, November 9th. This is a positive change from Clinigen Group PLC’s previous dividend of $1.60.

COPYRIGHT VIOLATION NOTICE: “Clinigen Group PLC (CLIN) Given Average Recommendation of “Buy” by Brokerages” was first reported by American Banking News and is the sole property of of American Banking News. If you are viewing this news story on another domain, it was illegally copied and reposted in violation of U.S. and international copyright law. The legal version of this news story can be accessed at https://www.americanbankingnews.com/2017/11/07/clinigen-group-plc-clin-given-average-recommendation-of-buy-by-brokerages.html.

In other news, insider John Bacon sold 250,000 shares of the business’s stock in a transaction dated Monday, October 2nd. The stock was sold at an average price of GBX 1,093 ($14.38), for a total value of £2,732,500 ($3,593,976.06). Also, insider Shaun Edward Chilton sold 100,000 shares of the business’s stock in a transaction dated Friday, October 13th. The shares were sold at an average price of GBX 1,150 ($15.13), for a total value of £1,150,000 ($1,512,560.83).

Clinigen Group PLC Company Profile

Analyst Recommendations for Clinigen Group PLC (LON:CLIN)

Receive News & Ratings for Clinigen Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clinigen Group PLC and related companies with MarketBeat.com's FREE daily email newsletter.